Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent expiration date of guselkumab?Patent expiry trametinib?Is allopurinol expensive?Sun pharma bortezomib?Children's ibuprofen price?
See the DrugPatentWatch profile for dupixent
Dupixent’s reported Q4 2020 sales growth was driven by the United States and several international markets, with the strongest contribution coming from continued momentum in the U.S. and growth outside the U.S. as well. [1]
Across Q4 2020, management reported that U.S. gains continued alongside international growth, meaning the overall quarter’s increase was not limited to a single geography. [1]
The company attributed the international portion of the growth broadly to ex-U.S. markets rather than isolating one country as the sole driver for the quarter. [1]
Other Questions About Dupixent :